Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep829 | Reproductive and Developmental Endocrinology | ECE2020

Gut microbiota and oral contraceptive use in polycystic ovary syndrome

Eyupoglu Damla , Ergunay Koray , Acikgoz Aylin , Akyon Yakut , Yilmaz Engin , Okan Yildiz Bulent

Context: Polycystic ovary syndrome (PCOS) is a common and complex endocrine disorder. Emerging animal and human data point out to various changes in microbiota that could be linked with the syndrome. However, the effects of therapeutic approaches on gut microbial composition in women with PCOS remain unknown.Objective: We aimed to assess whether gut microbial composition is altered in overweight/obese women with PCOS and to determine potential impact of ...

ea0063gp248 | Disturbances of Reproduction | ECE2019

Gut microbiota-dependent cardiometabolic risk and oral contraceptive use in polycystic ovary syndrome: A prospective study

Eyupoglu Damla , Caliskan Guzelce Ezgi , Acikgoz Aylin , Uyanik Esra , Bjorndal Bodil , Berge Rolf , Svardal Asbjorn , Okan Yildiz Bulent

Context: Polycystic ovary syndrome (PCOS) is associated with an increased cardiometabolic risk that might not necessarily translate into adverse cardiovascular outcome later in life. Recently, alterations in gut microbial composition have been reported in the syndrome. Microbiota-dependent metabolite trimethylamine N-oxide (TMAO) and its precursors are closely linked with development of atherosclerotic cardiovascular disease, independently of traditional risk factors.<p cl...